What gets lost when iboga is reduced to ibogaine, and complex care is reduced to protocol? In this op-ed, Paije West and Fletcher Burdick argue that safety, lineage, context, and individualized care cannot be separated so easily.

The post Op-Ed: Ibo...

Dear Colleagues,We write as a collective of practitioners, researchers, clinicians, and integration specialists with direct, long-term experience working with iboga and ibogaine across a range of settings. The growing interest in ibogaine within the United States — including public investment, emerging clinical pathways, and public-private partnerships — represents a meaningf...

Dr. Michael Alpert and Peter Alberding discuss ALS, ketamine-assisted psychotherapy, end-of-life fear, music, trust, and how one patient used ketamine to face mortality with more clarity and less fear.

The post

A look at Sonoran Desert toad medicine through the lens of indigenous sovereignty, ecological strain, and the debate over synthetic versus naturally sourced 5-MeO-DMT.

The post Inclius Alvarious’s Place Within Indigenous Soc...

Shane Mauss is an award-winning comedian (Conan, Kimmel, Comedy Central, Prime) with a fondness for interviewing scientists about the bizarre and counterintuitive ways the mind works and turning what he learns into solo shows that blend philosophy with comedy. Originally recognized for his cerebral, absurdist writing and understated delivery, he veered off the traditional pat...